Brief: Grand Pharmaceutical Says Entered An Equity Investment Agreement With Itm Isotope Technologies Munich
16/02/2022 10:23
Feb 16 (Reuters) - Grand Pharmaceutical:
* ENTERED AN EQUITY INVESTMENT AGREEMENT WITH ITM ISOTOPE
TECHNOLOGIES MUNICH
* DEAL FOR 25 MILLION EUROS
* UNDER AGREEMENT, CO WILL SUBSCRIBE NEWLY ISSUED SHARES OF
ITM
COMPANY EQUIVALENT TO ABOUT 1.31% OF ITS ENLARGED SHARE CAPITAL
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement